Astepro



Indications and Reactions:

Role Indications Reactions
Primary
Rhinitis Allergic 24.3%
Sinusitis 16.2%
Hypersensitivity 10.8%
Multiple Allergies 10.8%
Nasal Congestion 10.8%
Rhinitis 10.8%
Seasonal Allergy 5.4%
Cough 2.7%
Nasal Disorder 2.7%
Nasopharyngitis 2.7%
Upper Respiratory Tract Infection 2.7%
Paraesthesia 11.1%
Blood Glucose Increased 7.4%
Chest Pain 7.4%
Nasal Congestion 7.4%
Parosmia 7.4%
Visual Impairment 7.4%
Abdominal Discomfort 3.7%
Ageusia 3.7%
Anosmia 3.7%
Blood Pressure Decreased 3.7%
Cognitive Disorder 3.7%
Concussion 3.7%
Documented Hypersensitivity To Administered Drug 3.7%
Hallucination 3.7%
Heart Rate Decreased 3.7%
Hypersensitivity 3.7%
Hyposmia 3.7%
Insomnia 3.7%
Memory Impairment 3.7%
Migraine 3.7%
Secondary
Chronic Obstructive Pulmonary Disease 11.5%
Gastrooesophageal Reflux Disease 7.7%
Pain 7.7%
Sinusitis 7.7%
Sleep Disorder 7.7%
Dyspnoea 5.8%
Hypersensitivity 5.8%
Hypertension 5.8%
Multiple Allergies 5.8%
Depression 3.8%
Hormone Level Abnormal 3.8%
Influenza 3.8%
Intervertebral Disc Protrusion 3.8%
Nausea 3.8%
Product Used For Unknown Indication 3.8%
Rhinitis 3.8%
Hypogammaglobulinaemia 1.9%
Osteoporosis Postmenopausal 1.9%
Rhinitis Allergic 1.9%
Upper-airway Cough Syndrome 1.9%
Heart Rate Increased 16.7%
Chest Pain 11.1%
Tremor 11.1%
Ageusia 5.6%
Anosmia 5.6%
Contusion 5.6%
Dyspnoea 5.6%
Hypoaesthesia Oral 5.6%
Product Label Confusion 5.6%
Product Taste Abnormal 5.6%
Rash 5.6%
Rhinorrhoea 5.6%
Swollen Tongue 5.6%
Vision Blurred 5.6%
Concomitant
Product Used For Unknown Indication 42.0%
Asthma 10.2%
Drug Use For Unknown Indication 9.5%
Hypersensitivity 6.6%
Hypertension 5.7%
Pain 3.8%
Gastrooesophageal Reflux Disease 3.0%
Blood Cholesterol Increased 2.0%
Rheumatoid Arthritis 1.9%
Seasonal Allergy 1.9%
Nausea 1.8%
Anxiety 1.5%
Back Pain 1.5%
Prophylaxis 1.5%
Diabetes Mellitus 1.4%
Supplementation Therapy 1.4%
Multiple Allergies 1.3%
Depression 1.0%
Migraine 1.0%
Rhinitis Allergic 1.0%
Status Asthmaticus 11.1%
Pain 9.1%
Asthma 6.1%
Dehydration 6.1%
Flushing 6.1%
Drug Ineffective 5.1%
Dyspnoea 5.1%
Pruritus 5.1%
White Blood Cell Count Decreased 5.1%
Hypersensitivity 4.0%
Injection Site Haemorrhage 4.0%
Pyrexia 4.0%
Sinusitis 4.0%
Throat Irritation 4.0%
Upper Respiratory Tract Infection 4.0%
Vision Blurred 4.0%
Weight Increased 4.0%
Anaphylactic Reaction 3.0%
Anosmia 3.0%
Blood Pressure Increased 3.0%